Medtronic plc Stock News

When we imagine dividend aristocrats, a handful of big names take the spotlight. AT&T (NYSE: T ), Realty Income (NYSE: O ), Exxon Mobile (NYSE: XOM ) — these are some of the common names investors f

Medtronic PLC NYSE: MDT, a member of the medical sector and the healthcare industry, received U.S. FDA approval for its implantable medical device called the Percept PC Deep Brain Stimulation (DB

We outline an Income Strategy for creating a self-sufficient portfolio for retirees and income-focused investors with $1 million to generate a life-long income stream. We explain the benefits of gener

Medical device stocks have made a strong comeback in the past three months, becoming market leaders. Medtronic is a medical technology firm with a below-market valuation and a high forward dividend yi

While capital appreciation is vital, dividends are also important to total returns. Dividend stocks for consistent income provide both and are often more stable.

Medtronic (MDT) concluded the recent trading session at $87.09, signifying a +0.01% move from its prior day's close.

Medtronic's (MDT) latest innovation joins the Percept family, the first and only DBS system with sensing, directionality and advanced programming.

After underperforming the broad market over the past year, shares of Medtronic offer a 3.4% dividend yield. AbbVie shares offer a juicy 3.8% dividend yield even though the payout has grown 287% over t

Medtronic's stock has increased by 27.61% since my previous 'Buy' rated article, outperforming the S&P 500. But what's coming next? Medtronic continues to develop and expand its range of products, wit

Medtronic (MDT) secures the CE Mark for the MiniMed 780G system with the disposable, all-in-one Simplera Sync CGM.

International Wide-Moat Stocks On Sale - The January 2024 Heat Map

Medtronic plc (MDT) JPMorgan 42nd Annual Global Healthcare Conference (Transcript)

The medical device manufacturer won approval for a neurological product. Its latest Percept neurostimulator has been greenlighted by the U.S. FDA.

Medtronic CEO Geoffrey Martha, with CNBC's Jim Cramer, joins 'The Exchange' to discuss the impact of weight-loss drugs, AI-driven care, and more.

In the wearable medical devices industry, investors can keep a keen eye on stocks such as ABT, MDT and DXCM.